Octreotide Teva 20

Product TA
Oncology
Active Ingredient
Octreotide acetate
Product type
Prolonged release suspension for injection
Route Of Administration
Parenteral
Octreotide Teva 20

Product Details

Strength
20 mg
Pack Size
1
Scheduling status
S4
Registration Number
54/34/0426

Additional products

Doxorubicin-Sol PCH 10 mg

RouteOfAdministration
Intravenous
Product Type
Solution for injection
Learn more

Oxaliplatin PCH 50

RouteOfAdministration
Parenteral
Product Type
Concentrate for solution for infusion
Learn more

Dasatinib 100 Teva

RouteOfAdministration
Oral
Product Type
Film-coated tablet
Learn more

Telonta 25

RouteOfAdministration
Oral
Product Type
Film-coated tablet
Learn more